vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与合众银行（STBA）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$102.1M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 2.6%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
合众银行是总部位于美国明尼苏达州明尼阿波利斯、注册地为特拉华州的跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为系统重要性机构。旗下核心运营主体为美国合众银行全国协会，以“U.S. Bank”品牌开展业务，提供银行、投资、抵押贷款等多元金融服务。
PBYI vs STBA — 直观对比
营收规模更大
STBA
是对方的1.4倍
$75.5M
两年增速更快
PBYI
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $102.1M |
| 净利润 | — | $35.1M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 34.4% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | 5.0% |
| 每股收益（稀释后） | $0.26 | $0.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISTBA
| Q1 26 | — | $102.1M | ||
| Q4 25 | $75.5M | $105.3M | ||
| Q3 25 | $54.5M | $103.0M | ||
| Q2 25 | $52.4M | $100.1M | ||
| Q1 25 | $46.0M | $93.8M | ||
| Q4 24 | $59.1M | $94.3M | ||
| Q3 24 | $80.5M | $96.4M | ||
| Q2 24 | $47.1M | $96.9M |
净利润PBYISTBA
| Q1 26 | — | $35.1M | ||
| Q4 25 | — | $34.0M | ||
| Q3 25 | $8.8M | $35.0M | ||
| Q2 25 | $5.9M | $31.9M | ||
| Q1 25 | $3.0M | $33.4M | ||
| Q4 24 | — | $33.1M | ||
| Q3 24 | $20.3M | $32.6M | ||
| Q2 24 | $-4.5M | $34.4M |
毛利率PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
营业利润率PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | 40.3% | ||
| Q3 25 | 17.6% | 42.6% | ||
| Q2 25 | 12.7% | 40.0% | ||
| Q1 25 | 8.7% | 44.5% | ||
| Q4 24 | 22.6% | 43.8% | ||
| Q3 24 | 27.4% | 43.0% | ||
| Q2 24 | -4.6% | 44.2% |
净利率PBYISTBA
| Q1 26 | — | 34.4% | ||
| Q4 25 | — | 32.3% | ||
| Q3 25 | 16.2% | 33.9% | ||
| Q2 25 | 11.2% | 31.9% | ||
| Q1 25 | 6.5% | 35.6% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | 25.2% | 33.8% | ||
| Q2 24 | -9.6% | 35.5% |
每股收益（稀释后）PBYISTBA
| Q1 26 | — | $0.94 | ||
| Q4 25 | $0.26 | $0.88 | ||
| Q3 25 | $0.17 | $0.91 | ||
| Q2 25 | $0.12 | $0.83 | ||
| Q1 25 | $0.06 | $0.87 | ||
| Q4 24 | $0.40 | $0.86 | ||
| Q3 24 | $0.41 | $0.85 | ||
| Q2 24 | $-0.09 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $100.8M |
| 股东权益账面价值 | $130.3M | $1.4B |
| 总资产 | $216.3M | $9.9B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $163.4M | ||
| Q3 25 | $94.4M | $196.2M | ||
| Q2 25 | $96.0M | $203.1M | ||
| Q1 25 | $93.2M | $211.8M | ||
| Q4 24 | $101.0M | $244.8M | ||
| Q3 24 | $96.7M | $228.1M | ||
| Q2 24 | $96.8M | $246.3M |
总债务PBYISTBA
| Q1 26 | — | $100.8M | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYISTBA
| Q1 26 | — | $1.4B | ||
| Q4 25 | $130.3M | $1.5B | ||
| Q3 25 | $115.3M | $1.5B | ||
| Q2 25 | $104.7M | $1.4B | ||
| Q1 25 | $97.1M | $1.4B | ||
| Q4 24 | $92.1M | $1.4B | ||
| Q3 24 | $71.1M | $1.4B | ||
| Q2 24 | $48.5M | $1.3B |
总资产PBYISTBA
| Q1 26 | — | $9.9B | ||
| Q4 25 | $216.3M | $9.9B | ||
| Q3 25 | $202.9M | $9.8B | ||
| Q2 25 | $194.9M | $9.8B | ||
| Q1 25 | $196.2M | $9.7B | ||
| Q4 24 | $213.3M | $9.7B | ||
| Q3 24 | $220.7M | $9.6B | ||
| Q2 24 | $205.0M | $9.6B |
负债/权益比PBYISTBA
| Q1 26 | — | 0.07× | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $133.6M | ||
| Q3 25 | $9.7M | $40.5M | ||
| Q2 25 | $14.1M | $28.3M | ||
| Q1 25 | $3.6M | $28.7M | ||
| Q4 24 | $15.6M | $173.4M | ||
| Q3 24 | $11.0M | $27.6M | ||
| Q2 24 | $1.0M | $44.7M |
自由现金流PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $128.8M | ||
| Q3 25 | $9.7M | $39.9M | ||
| Q2 25 | $14.1M | $27.1M | ||
| Q1 25 | $3.6M | $27.0M | ||
| Q4 24 | $15.6M | $170.4M | ||
| Q3 24 | $11.0M | $26.9M | ||
| Q2 24 | $1.0M | $43.9M |
自由现金流率PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 122.4% | ||
| Q3 25 | 17.7% | 38.7% | ||
| Q2 25 | 26.8% | 27.1% | ||
| Q1 25 | 7.7% | 28.8% | ||
| Q4 24 | 26.4% | 180.7% | ||
| Q3 24 | 13.7% | 28.0% | ||
| Q2 24 | 2.1% | 45.3% |
资本支出强度PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 4.5% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.1% | 1.8% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 0.9% |
现金转化率PBYISTBA
| Q1 26 | — | — | ||
| Q4 25 | — | 3.93× | ||
| Q3 25 | 1.10× | 1.16× | ||
| Q2 25 | 2.41× | 0.89× | ||
| Q1 25 | 1.21× | 0.86× | ||
| Q4 24 | — | 5.24× | ||
| Q3 24 | 0.54× | 0.85× | ||
| Q2 24 | — | 1.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
STBA
| Net Interest Income | $88.4M | 87% |
| Noninterest Income | $13.6M | 13% |
